Advertisement
Johnson & Johnson

Johnson & Johnson (JNJ) Stock Overview

Explore Johnson & Johnson’s financial performance, market position, analyst ratings, and future outlook.

JNJNYSE
HealthcareDrug Manufacturers - General
$254.66
$9.78(3.99%)
U.S. Market opens in 43h 26m
Advertisement

Johnson & Johnson (JNJ)

Meyka AI Score

Z

Key Financials

Market Cap612.8B
P/E Ratio29.25
EPS (TTM)$11.03
ROE0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$252.01
3 Months$265.21
1 Year Target$192.19

JNJ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Johnson & Johnson (JNJ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 72.02, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $192.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.25 and a market capitalization of 612.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.85%
5-Day Change
11.08%
1-Month Change
10.48%
3-Month Change
6.29%
6-Month Change
22.48%
Year-to-Date (YTD) Change
22.88%
1-Year Change
67.30%
3-Year Change
55.42%
5-Year Change
55.05%
All-Time (Max) Change
20745.08%

Contact Information

732 524 0400
One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Company Facts

1,417,000 Employees
IPO DateJan 2, 1962
CountryUS
Actively Trading

Frequently Asked Questions